Up to 15,000 cancer patients a year could be treated with a quick injection, NHS England has announced.
It is the first health service in Europe to offer patients the injectable form of the immunotherapy drug nivolumab.
Up to 15,000 cancer patients a year could be treated with a quick injection, NHS England has announced.
It is the first health service in Europe to offer patients the injectable form of the immunotherapy drug nivolumab.